Рус Eng

+7 (495) 510-32-88

Reviews of the press - ZAO Binnopharm

{08.04.2011}

AstraZeneca and UCB agree to help fund Russian pharma innovation

Swedish-British AstraZeneca has inked a deal with the RF to fund innovative biotech projects across Russia. And Belgium’s UCB Pharma and Russia’s Binnopharm are pooling efforts in R&D and marketing with an eye to local production and extending R&D to Russian university sites. With its 10-20% annual growth rates Russia’s biotech market is becoming increasingly attractive for global pharmaceutical majors.

{05.04.2011}

UPDATE 1-UCB goes local in Russia with Binnopharm deal

MOSCOW, April 5 (Reuters) - Belgian drugmaker UCB will sign an agreement on Tuesday with Russia's Sistema's unit Binnopharm for local packaging and production, to boost its presence on the rapidly growing Russian market.

CJSC «BINNOPHARM» 3/1, 4-th Zapadny proezd, Zelenograd, Moscow, 124460, Russia, tel./fax +7 (495) 229-78-00
Office in Moscow: 4-th 8 Marta Street, 6A, tel./fax +7 (495) 510-32-88

© 2012 Binnopharm
Web design, site development - Techart.